| DIRECT COMPETITOR COMPARISON | |
| IG | Pvt1 | Pvt2 | Pvt3 | Industry | | Market Cap: | 16.42M | N/A | N/A | N/A | 97.36M | | Employees: | 23 | 5741 | 451 | 4,5001 | 65 | | Qtrly Rev Growth (yoy): | -18.00% | N/A | N/A | N/A | 19.70% | | Revenue (ttm): | 3.45M | 233.50M1 | 6.20M1 | 717.30M1 | 14.01M | | Gross Margin (ttm): | 10.24% | N/A | N/A | N/A | 65.68% | | EBITDA (ttm): | -3.09M | N/A | N/A | N/A | -12.25M | | Oper Margins (ttm): | -99.80% | N/A | N/A | N/A | -137.11% | | Net Income (ttm): | -7.00M | N/A | N/A | -1.40M1 | N/A | | EPS (ttm): | -0.433 | N/A | N/A | N/A | -0.31 | | P/E (ttm): | N/A | N/A | N/A | N/A | 17.26 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.28 | | P/S (ttm): | 4.76 | N/A | N/A | N/A | 9.82 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 55.93 | 0.00% | 56.61B | 12.20 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.06 | 0.00% | 13.90B | 16.08 | | Genzyme Corp. | GENZ | 49.42 | 0.00% | 13.12B | 28.18 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.12 | 0.00% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.87 | 0.00% | 8.89B | 1017.76 | | Teva Pharmaceutical Industries Limited | TEVA | 52.44 | 0.00% | 46.20B | 47.98 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.77 | 0.00% | 4.01B | 19.47 | | King Pharmaceuticals Inc. | KG | 11.30 | 0.00% | 2.81B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.14 | 0.00% | 5.54B | 111.29 | | Pfizer Inc. | PFE | 17.76 | 0.00% | 143.31B | 14.75 | | Johnson & Johnson | JNJ | 64.25 | 0.00% | 177.27B | 14.03 | | GlaxoSmithKline plc | GSK | 42.05 | 0.00% | 106.60B | 13.39 | | Sanofi-Aventis | SNY | 38.73 | 0.00% | 101.13B | N/A | | Novartis AG | NVS | 55.33 | 0.00% | 125.67B | 16.57 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 40.80 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.70 | 0.00% | 66.27B | 9.18 | | Abbott Laboratories | ABT | 53.24 | 0.00% | 82.35B | 14.42 | | Bristol-Myers Squibb Co. | BMY | 24.90 | 0.00% | 49.33B | 12.88 |
|
| NEWS ON DIRECT COMPETITORS | | No News on Direct Competitors |
|
|